Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2032

 ATTRIBUTE

 DETAILS

Study Period

  2015-2026

Base Year

  2018

Forecast Period

  2019-2026

Historical Period

  2015-2017

Unit

  Value (USD billion)

Segmentation

By Drug Class

• Immunomodulators


• Proteasome Inhibitor


• Anti-CD38 Monoclonal Antibody


• Alkylating Agents


• Others

By Distribution Channel

• Hospital Pharmacies


• Retail Pharmacies & Drug Stores


• Online Pharmacies

By Geography

• North America (U.S. and Canada)


• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)


• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)


• Latin America (Brazil, Mexico, and the Rest of Latin America)


• Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)